Baird Medical Investment Holdings(BDMD)
$0.10+0.01 (+7.22%)
BDMD
Baird Medical Investment Holdings financials statements
$0.10
At close:+0.01 (+7.22%)
Want to see BDMD full AI Analyst Report?
Baird Medical Investment Holdings (BDMD) Ratios
70 Followers
Baird Medical Investment Holdings Ratios
BDMD's free cash flow for Q2 2026 was $2.46M. For the 2026 fiscal year, BDMD's free cash flow was increased by $0.00 and operating cash flow was $2.46M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.70 | 1.77 | 2.11 | 2.11 | 2.29 |
| Quick Ratio | 1.66 | 1.74 | 2.05 | 2.03 | 1.98 |
| Cash Ratio | 0.01 | 0.09 | 0.08 | 0.11 | 0.31 |
| Solvency Ratio | -0.68 | 0.37 | 0.55 | 0.83 | 1.27 |
| Operating Cash Flow Ratio | -0.04 | -0.18 | -0.05 | 0.03 | 0.54 |
| Short-Term Operating Cash Flow Coverage | -0.10 | -0.37 | -0.12 | 0.08 | 2.58 |
| Net Current Asset Value | $ 16.49M | $ 23.21M | $ 19.08M | $ 16.92M | $ 12.14M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.28 | 0.27 | 0.17 | 0.17 | 0.11 |
| Debt-to-Equity Ratio | 0.62 | 0.53 | 0.28 | 0.29 | 0.56 |
| Debt-to-Capital Ratio | 0.38 | 0.34 | 0.22 | 0.22 | 0.36 |
| Long-Term Debt-to-Capital Ratio | 0.16 | 0.08 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 2.22 | 1.97 | 1.59 | 1.64 | 5.02 |
| Debt Service Coverage Ratio | -1.86 | 0.83 | 1.32 | 2.23 | 5.35 |
| Interest Coverage Ratio | -34.63 | 26.55 | 41.73 | 45.55 | 77.42 |
| Debt to Market Cap | 0.51 | 0.11 | 0.10 | 0.10 | 0.03 |
| Interest Debt Per Share | 0.72 | 0.84 | 1.34 | 1.23 | 0.43 |
| Net Debt to EBITDA | -0.78 | 1.11 | 0.65 | 0.35 | -0.01 |
| Profitability Margins | |||||
| Gross Profit Margin | 83.79% | 88.16% | 86.56% | 79.90% | 83.61% |
| EBIT Margin | -113.76% | 39.59% | 37.71% | 42.24% | 46.03% |
| EBITDA Margin | -108.86% | 43.66% | 40.93% | 46.43% | 51.08% |
| Operating Profit Margin | -113.31% | 41.35% | 37.71% | 38.85% | 42.99% |
| Pretax Profit Margin | -117.03% | 38.04% | 39.29% | 41.38% | 45.47% |
| Net Profit Margin | -121.04% | 33.62% | 33.52% | 35.82% | 42.12% |
| Continuous Operations Profit Margin | -122.20% | 34.01% | 33.88% | 36.41% | 36.73% |
| Net Income Per EBT | 103.42% | 88.40% | 85.33% | 86.55% | 92.63% |
| EBT Per EBIT | 103.28% | 91.98% | 104.19% | 106.53% | 105.78% |
| Return on Assets (ROA) | -39.14% | 15.97% | 18.60% | 29.49% | 44.70% |
| Return on Equity (ROE) | -86.96% | 31.40% | 29.50% | 48.47% | 224.40% |
| Return on Capital Employed (ROCE) | -68.40% | 35.34% | 31.44% | 51.26% | 72.86% |
| Return on Invested Capital (ROIC) | -50.55% | 22.59% | 21.66% | 36.10% | 51.21% |
| Return on Tangible Assets | -39.17% | 15.99% | 18.62% | 29.57% | 44.92% |
| Earnings Yield | -72.17% | 6.41% | 12.98% | 19.49% | 16.48% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.53 | 0.80 | 1.00 | 1.42 | 2.23 |
| Payables Turnover | 2.02 | 3.50 | 7.68 | 32.68 | 13.36 |
| Inventory Turnover | 3.36 | 3.38 | 3.70 | 5.45 | 1.49 |
| Fixed Asset Turnover | 3.44 | 4.86 | 4.49 | 12.86 | 8.34 |
| Asset Turnover | 0.32 | 0.48 | 0.55 | 0.82 | 1.06 |
| Working Capital Turnover Ratio | 0.91 | 1.55 | 1.62 | 2.31 | 3.37 |
| Cash Conversion Cycle | 616.97 | 462.69 | 416.57 | 313.32 | 382.01 |
| Days of Sales Outstanding | 688.83 | 459.03 | 365.42 | 257.58 | 163.89 |
| Days of Inventory Outstanding | 108.48 | 107.97 | 98.65 | 66.91 | 245.44 |
| Days of Payables Outstanding | 180.34 | 104.31 | 47.50 | 11.17 | 27.33 |
| Operating Cycle | 797.31 | 567.00 | 464.08 | 324.49 | 409.33 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.05 | -0.25 | -0.13 | 0.08 | 0.73 |
| Free Cash Flow Per Share | -0.05 | -0.36 | -0.48 | -0.87 | 0.54 |
| Dividend Paid and CapEx Coverage Ratio | -31.76 | -2.21 | -0.39 | 0.08 | 0.77 |
| Capital Expenditure Coverage Ratio | -31.76 | -2.21 | -0.39 | 0.08 | 3.79 |
| Operating Cash Flow Coverage Ratio | -0.07 | -0.30 | -0.10 | 0.07 | 1.79 |
| Operating Cash Flow to Sales Ratio | -0.06 | -0.17 | -0.03 | 0.01 | 0.19 |
| Free Cash Flow Yield | -3.67% | -4.72% | -4.50% | -8.48% | 5.46% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -1.39 | 15.60 | 7.70 | 5.13 | 6.07 |
| Price-to-Sales (P/S) Ratio | 1.68 | 5.24 | 2.58 | 1.84 | 2.56 |
| Price-to-Book (P/B) Ratio | 1.21 | 4.90 | 2.27 | 2.49 | 13.62 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -27.26 | -21.19 | -22.20 | -11.80 | 18.32 |
| Price-to-Operating Cash Flow Ratio | -28.12 | -30.76 | -79.63 | 132.72 | 13.49 |
| Price-to-Earnings Growth (PEG) Ratio | 0.00 | 0.80 | 0.00 | -0.03 | -0.06 |
| Enterprise Value Multiple | -2.32 | 13.12 | 6.96 | 4.31 | 5.00 |
| Enterprise Value | 56.92M | 212.13M | 89.61M | 70.23M | 70.77M |
| EV to EBITDA | -2.32 | 13.12 | 6.96 | 4.31 | 5.00 |
| EV to Sales | 2.53 | 5.73 | 2.85 | 2.00 | 2.55 |
| EV to Free Cash Flow | -41.06 | -23.14 | -24.49 | -12.84 | 18.30 |
| EV to Operating Cash Flow | -42.35 | -33.60 | -87.86 | 144.51 | 13.47 |
| Tangible Book Value Per Share | 1.12 | 1.55 | 4.70 | 4.08 | 2.19 |
| Shareholders’ Equity Per Share | 1.13 | 1.55 | 4.71 | 4.13 | 0.72 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.04 | 0.11 | 0.14 | 0.12 | 0.19 |
| Revenue Per Share | 0.81 | 1.45 | 4.15 | 5.58 | 3.86 |
| Net Income Per Share | -0.98 | 0.49 | 1.39 | 2.00 | 1.62 |
| Tax Burden | 1.03 | 0.88 | 0.85 | 0.87 | 0.93 |
| Interest Burden | 1.03 | 0.96 | 1.04 | 0.98 | 0.99 |
| Research & Development to Revenue | 0.89 | 0.17 | 0.14 | 0.11 | 0.04 |
| SG&A to Revenue | 1.08 | 0.27 | 0.27 | 0.20 | 0.24 |
| Stock-Based Compensation to Revenue | 0.78 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.05 | -0.50 | -0.10 | 0.04 | 0.52 |
Currency in USD
